Results 71 to 80 of about 2,408 (165)

Long-term survival of a kidney transplant patient with advanced renal cancer after combination therapy: a case report and literature review

Journal of International Medical Research
De novo renal transplant carcinoma, especially in the context of bilateral renal carcinoma, is rare and often presents as small, low-grade papillary renal cell carcinoma (RCC).
Chao Peng, Weihao Wang, Jiajun Chen, Shouhua Pan, Gang Xu, Mengyao Li, Lulu Zhang, Yulei Li, Keyuan Zhao, Jing Jin   +9 more
doaj   +1 more source

Systematic Review: Perioperative Systemic Therapy for Metastatic Renal Cell Carcinoma

Kidney Cancer, 2017
Background:  Approximately 16% of patients with renal cell carcinomas (RCC) present with stage IV disease at time of diagnosis. Treatment options for metastatic clear cell RCC, the most common histologic subtype, have proliferated over the past decade ...
Patrick G. Pilié, Eric Jonasch
doaj   +1 more source

Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic

Research and Reports in Urology
Jonathan Chatzkel,1 Mayer Fishman,2 Brian Ramnaraign,1 Padraic O’Malley,3 Guru P Sonpavde4 1Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA; 2University of South Florida, Tampa, FL, USA ...
Chatzkel J, Fishman M, Ramnaraign B, O’Malley P, Sonpavde GP   +4 more
doaj  

Isolated Scalp Nodule in Patient with Undiagnosed RCC

The Scientific World Journal, 2006
An unexpected diagnosis of metastatic RCC after excision biopsy of a skin nodule can bring uncertainty. A case of isolated scalp metastasis from undiagnosed RCC was noted and a review of the literature was undertaken to aid management. RCCs often present
David Pan, Owen Niall, Harbinder Sharma, Devan Gya   +3 more
doaj   +1 more source

The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.

PLoS ONE, 2019
BackgroundThere has been significant uncertainty in the selection of candidates for cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC).
Zhijian Zhao, Wenqi Wu, Xiaolu Duan, Guohua Zeng, Yongda Liu   +4 more
doaj   +1 more source

Analysis of the impact of cytoreductive surgery in patients with oligometastatic renal cell carcinoma in clinical practice

Сибирский онкологический журнал
Cytoreductive nephrectomy (CN) and metastasectomy are justified in patients with oligometastatic renal cell carcinoma (RCC). Objective: to evaluate the impact of cytoreductive surgery on survival rates in patients with oligometastatic RCС.
D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritsky, M. I. Gluzman, Yu. S. Korneva   +5 more
doaj   +1 more source

A case of papillary renal cell carcinoma with para‐aortic lymph node metastasis that was completely resectable after treatment with combination therapy comprising lenvatinib and pembrolizumab and robot‐assisted radical nephrectomy

IJU Case Reports
Introduction Combination therapy comprising immune checkpoint inhibitors and molecular targeted therapies can be effective for metastatic non‐clear cell renal cell carcinoma.
Takayuki Hosoi, Shunsuke Yoshioka, Akari Hiraguri, Yusuke Kirihana, Tomoyuki Koguchi, Makoto Tamaki, Chiharu Irisawa   +6 more
doaj   +1 more source

Cytoreductive nephrectomy: a treatment of the past

Canadian Urological Association Journal, 2013
openaire   +3 more sources

The role of cytoreductive nephrectomy in the treatment of patients with metastatic kidney cancer - review article. [PDF]

Contemp Oncol (Pozn), 2023
Michalak M, Tomczak P, Milecki T, Antczak A.   +3 more
europepmc   +1 more source

Role of cytoreductive nephrectomy in metastatic medullary renal cell carcinoma: controlled analysis. [PDF]

World J Urol
Le QC, Marmiroli A, Longoni M, Falkenbach F, Catanzaro C, Nicolazzini M, Polverino F, Goyal JA, Saad F, Schiavina R, Carmignani LF, Briganti A, Longo N, Graefen M, Palumbo C, Siech C, Banek S, Traumann M, Chun FK, Karakiewicz PI.   +19 more
europepmc   +1 more source